• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阴离子微粒是一种用于递送B型脑膜炎奈瑟菌重组抗原的有效递送系统。

Anionic microparticles are a potent delivery system for recombinant antigens from Neisseria meningitidis serotype B.

作者信息

Singh Manmohan, Kazzaz Jina, Chesko James, Soenawan Elawati, Ugozzoli Mildred, Giuliani Marzia, Pizza Mariagrazia, Rappouli Rino, O'Hagan Derek T

机构信息

Chiron Vaccines Research, Chiron Corporation, 4560 Horton Street, Emeryville, CA 94608, USA.

出版信息

J Pharm Sci. 2004 Feb;93(2):273-82. doi: 10.1002/jps.10538.

DOI:10.1002/jps.10538
PMID:14705185
Abstract

The adsorption behavior of model proteins onto anionic poly(lactide-co-glycolide) (PLG) microparticles was evaluated. PLG microparticles were prepared by a w/o/w solvent evaporation process in the presence of the anionic surfactant dioctyl sodium sulfosuccinate (DSS). The effect of surfactant concentration and adsorption conditions on the adsorption efficiency and release rates in vitro was also studied. Subsequently, the microparticle formulation was tested to evaluate the efficacy of anionic microparticles as delivery systems for recombinant antigens from Neisseria meningitides type B (Men B), with and without CpG adjuvant. Protein (antigen) binding to anionic PLG microparticles was influenced by both electrostatic interaction and by other mechanisms, including hydrophobic attraction. The Men B antigens adsorbed efficiently onto anionic PLG microparticles and, following immunization in mice, induced potent enzyme-linked immunosorbent assay (ELISA) and serum bactericidal activity in comparison to alum-adsorbed formulations. These Men B antigens represent an attractive approach for vaccine development.

摘要

评估了模型蛋白在阴离子聚(丙交酯 - 乙交酯)(PLG)微粒上的吸附行为。PLG微粒是在阴离子表面活性剂磺基琥珀酸二辛酯钠(DSS)存在下通过w/o/w溶剂蒸发法制备的。还研究了表面活性剂浓度和吸附条件对体外吸附效率和释放速率的影响。随后,测试了微粒制剂,以评估阴离子微粒作为携带B型脑膜炎奈瑟菌(Men B)重组抗原的递送系统的功效,有无CpG佐剂。蛋白质(抗原)与阴离子PLG微粒的结合受静电相互作用和其他机制(包括疏水吸引)的影响。Men B抗原有效地吸附到阴离子PLG微粒上,并且在小鼠免疫后,与明矾吸附制剂相比,诱导了高效的酶联免疫吸附测定(ELISA)和血清杀菌活性。这些Men B抗原代表了一种有吸引力的疫苗开发方法。

相似文献

1
Anionic microparticles are a potent delivery system for recombinant antigens from Neisseria meningitidis serotype B.阴离子微粒是一种用于递送B型脑膜炎奈瑟菌重组抗原的有效递送系统。
J Pharm Sci. 2004 Feb;93(2):273-82. doi: 10.1002/jps.10538.
2
An investigation of the factors controlling the adsorption of protein antigens to anionic PLG microparticles.对控制蛋白质抗原吸附到阴离子型聚乳酸-乙醇酸共聚物微粒的因素的研究。
J Pharm Sci. 2005 Nov;94(11):2510-9. doi: 10.1002/jps.20472.
3
Characterization of antigens adsorbed to anionic PLG microparticles by XPS and TOF-SIMS.通过X射线光电子能谱(XPS)和飞行时间二次离子质谱(TOF-SIMS)对吸附在阴离子聚乳酸-乙醇酸共聚物(PLG)微粒上的抗原进行表征。
J Pharm Sci. 2008 Apr;97(4):1443-53. doi: 10.1002/jps.21040.
4
Polylactide-co-glycolide microparticles with surface adsorbed antigens as vaccine delivery systems.以表面吸附抗原的聚乳酸-羟基乙酸共聚物微粒作为疫苗递送系统。
Curr Drug Deliv. 2006 Jan;3(1):115-20. doi: 10.2174/156720106775197565.
5
Encapsulation of the immune potentiators MPL and RC529 in PLG microparticles enhances their potency.将免疫增强剂MPL和RC529包裹于聚乳酸-乙醇酸共聚物(PLG)微粒中可增强其效力。
J Control Release. 2006 Feb 21;110(3):566-73. doi: 10.1016/j.jconrel.2005.10.010. Epub 2005 Dec 19.
6
A comparison of anionic nanoparticles and microparticles as vaccine delivery systems.作为疫苗递送系统的阴离子纳米颗粒和微粒的比较
Hum Vaccin. 2008 Jan-Feb;4(1):44-9. doi: 10.4161/hv.4.1.4886. Epub 2007 Aug 15.
7
The potency of the adjuvant, CpG oligos, is enhanced by encapsulation in PLG microparticles.佐剂CpG寡核苷酸通过包裹于聚乳酸-乙醇酸共聚物(PLG)微粒中而增强其效力。
J Pharm Sci. 2008 Mar;97(3):1155-64. doi: 10.1002/jps.21065.
8
Adsorption of a novel recombinant glycoprotein from HIV (Env gp120dV2 SF162) to anionic PLG microparticles retains the structural integrity of the protein, whereas encapsulation in PLG microparticles does not.一种来自HIV的新型重组糖蛋白(Env gp120dV2 SF162)吸附到阴离子型聚乳酸-羟基乙酸共聚物(PLG)微粒上时,蛋白质的结构完整性得以保留,而包封在PLG微粒中则不然。
Pharm Res. 2004 Dec;21(12):2148-52. doi: 10.1007/s11095-004-7666-6.
9
Charged polylactide co-glycolide microparticles as antigen delivery systems.带电荷的聚乳酸-乙醇酸共聚物微粒作为抗原递送系统。
Expert Opin Biol Ther. 2004 Apr;4(4):483-91. doi: 10.1517/14712598.4.4.483.
10
Novel anionic microparticles are a potent adjuvant for the induction of cytotoxic T lymphocytes against recombinant p55 gag from HIV-1.新型阴离子微粒是诱导细胞毒性T淋巴细胞抵抗来自HIV-1的重组p55 gag的有效佐剂。
J Control Release. 2000 Jul 3;67(2-3):347-56. doi: 10.1016/s0168-3659(00)00226-1.

引用本文的文献

1
Considerations for Size, Surface Charge, Polymer Degradation, Co-Delivery, and Manufacturability in the Development of Polymeric Particle Vaccines for Infectious Diseases.传染病聚合物颗粒疫苗开发中尺寸、表面电荷、聚合物降解、共递送及可制造性的考量因素
Adv Nanobiomed Res. 2021 Mar;1(3):2000041. doi: 10.1002/anbr.202000041. Epub 2021 Jan 18.
2
Technological approaches to streamline vaccination schedules, progressing towards single-dose vaccines.简化疫苗接种计划的技术方法,朝着单剂量疫苗发展。
NPJ Vaccines. 2020 Sep 18;5:88. doi: 10.1038/s41541-020-00238-8. eCollection 2020.
3
Nanoparticle Vaccines Adopting Virus-like Features for Enhanced Immune Potentiation.
采用病毒样特征增强免疫增强作用的纳米颗粒疫苗。
Nanotheranostics. 2017 Jun 9;1(3):244-260. doi: 10.7150/ntno.19796. eCollection 2017.
4
Encapsulation-free controlled release: Electrostatic adsorption eliminates the need for protein encapsulation in PLGA nanoparticles.无囊泡控制释放:静电吸附消除了 PLGA 纳米粒中蛋白质囊泡化的需要。
Sci Adv. 2016 May 27;2(5):e1600519. doi: 10.1126/sciadv.1600519. eCollection 2016 May.
5
Peptide/protein vaccine delivery system based on PLGA particles.基于聚乳酸-羟基乙酸共聚物(PLGA)颗粒的肽/蛋白质疫苗递送系统。
Hum Vaccin Immunother. 2016 Mar 3;12(3):806-28. doi: 10.1080/21645515.2015.1102804.
6
Relationship between the size of nanoparticles and their adjuvant activity: data from a study with an improved experimental design.纳米颗粒大小与其佐剂活性之间的关系:一项采用改进实验设计的研究数据。
Eur J Pharm Biopharm. 2011 May;78(1):107-16. doi: 10.1016/j.ejpb.2010.12.017. Epub 2010 Dec 21.
7
Carnauba wax nanoparticles enhance strong systemic and mucosal cellular and humoral immune responses to HIV-gp140 antigen.巴西棕榈蜡纳米颗粒增强了对 HIV-gp140 抗原的强烈全身和黏膜细胞及体液免疫应答。
Vaccine. 2011 Feb 1;29(6):1258-69. doi: 10.1016/j.vaccine.2010.11.084. Epub 2010 Dec 9.
8
Uptake of particulate vaccine adjuvants by dendritic cells activates the NALP3 inflammasome.树突状细胞摄取颗粒性疫苗佐剂会激活NALP3炎性小体。
Proc Natl Acad Sci U S A. 2009 Jan 20;106(3):870-5. doi: 10.1073/pnas.0804897106. Epub 2009 Jan 12.
9
Vaccines: all things considered.疫苗:综合考量所有因素。
Clin Vaccine Immunol. 2006 Aug;13(8):821-9. doi: 10.1128/CVI.00152-06.
10
Adsorption of a novel recombinant glycoprotein from HIV (Env gp120dV2 SF162) to anionic PLG microparticles retains the structural integrity of the protein, whereas encapsulation in PLG microparticles does not.一种来自HIV的新型重组糖蛋白(Env gp120dV2 SF162)吸附到阴离子型聚乳酸-羟基乙酸共聚物(PLG)微粒上时,蛋白质的结构完整性得以保留,而包封在PLG微粒中则不然。
Pharm Res. 2004 Dec;21(12):2148-52. doi: 10.1007/s11095-004-7666-6.